Ainhoa Arina to Tumor Necrosis Factor Receptor Superfamily, Member 9
This is a "connection" page, showing publications Ainhoa Arina has written about Tumor Necrosis Factor Receptor Superfamily, Member 9.
Connection Strength
0.561
-
Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma. Clin Cancer Res. 2008 Nov 01; 14(21):6895-906.
Score: 0.325
-
In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb. Eur J Immunol. 2009 Sep; 39(9):2424-36.
Score: 0.086
-
Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens. Int J Cancer. 2004 May 20; 110(1):51-60.
Score: 0.060
-
Potentiation of therapeutic immune responses against malignancies with monoclonal antibodies. Clin Cancer Res. 2003 Nov 15; 9(15):5454-64.
Score: 0.058
-
[The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases]. An Sist Sanit Navar. 2006 Jan-Apr; 29(1):77-96.
Score: 0.017
-
Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus. Vaccine. 2005 May 20; 23(27):3493-9.
Score: 0.016